These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

619 related items for PubMed ID: 17628685

  • 1. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.
    Joeres S, Kaplowitz K, Brubaker JW, Updike PG, Collins AT, Walsh AC, Romano PW, Sadda SR.
    Ophthalmology; 2008 Feb; 115(2):347-354.e2. PubMed ID: 17628685
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ.
    Ophthalmology; 2006 Mar; 113(3):363-372.e5. PubMed ID: 16458968
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.
    Retina; 2007 Mar; 27(4):432-8. PubMed ID: 17420694
    [Abstract] [Full Text] [Related]

  • 4. Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration.
    Keane PA, Liakopoulos S, Chang KT, Wang M, Dustin L, Walsh AC, Sadda SR.
    Ophthalmology; 2008 Dec; 115(12):2206-14. PubMed ID: 18930551
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.
    Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML.
    Retina; 2007 Dec; 27(4):439-44. PubMed ID: 17420695
    [Abstract] [Full Text] [Related]

  • 6. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G.
    Retina; 2006 Dec; 26(5):495-511. PubMed ID: 16770255
    [Abstract] [Full Text] [Related]

  • 7. Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration.
    Keane PA, Patel PJ, Ouyang Y, Chen FK, Ikeji F, Walsh AC, Tufail A, Sadda SR.
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5431-7. PubMed ID: 20554607
    [Abstract] [Full Text] [Related]

  • 8. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.
    Melamud A, Stinnett S, Fekrat S.
    Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144
    [Abstract] [Full Text] [Related]

  • 9. Effect of intravitreal bevacizumab (Avastin) in neovascular age-related macular degeneration using a treatment regimen based on optical coherence tomography: 6- and 12-month results.
    Leydolt C, Michels S, Prager F, Garhoefer G, Georgopoulos M, Polak K, Schmidt-Erfurth U.
    Acta Ophthalmol; 2010 Aug; 88(5):594-600. PubMed ID: 19485959
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of optical coherence tomography retinal thickness parameters for use in clinical trials for neovascular age-related macular degeneration.
    Keane PA, Liakopoulos S, Jivrajka RV, Chang KT, Alasil T, Walsh AC, Sadda SR.
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3378-85. PubMed ID: 19264895
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage.
    Stifter E, Michels S, Prager F, Georgopoulos M, Polak K, Hirn C, Schmidt-Erfurth U.
    Am J Ophthalmol; 2007 Dec; 144(6):886-892. PubMed ID: 17916314
    [Abstract] [Full Text] [Related]

  • 12. Effect of ranibizumab retreatment frequency on neurosensory retinal volume in neovascular amd.
    Keane PA, Chang KT, Liakopoulos S, Jivrajka RV, Walsh AC, Sadda SR.
    Retina; 2009 May; 29(5):592-600. PubMed ID: 19289984
    [Abstract] [Full Text] [Related]

  • 13. Treatment of choroidal neovascularization using intravitreal bevacizumab.
    Pedersen R, Soliman W, Lund-Andersen H, Larsen M.
    Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757
    [Abstract] [Full Text] [Related]

  • 14. Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration.
    Kashani AH, Keane PA, Dustin L, Walsh AC, Sadda SR.
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3366-73. PubMed ID: 19168893
    [Abstract] [Full Text] [Related]

  • 15. Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration.
    Yoganathan P, Deramo VA, Lai JC, Tibrewala RK, Fastenberg DM.
    Retina; 2006 Jul; 26(9):994-8. PubMed ID: 17151485
    [Abstract] [Full Text] [Related]

  • 16. Reproducibility of quantitative optical coherence tomography subanalysis in neovascular age-related macular degeneration.
    Joeres S, Tsong JW, Updike PG, Collins AT, Dustin L, Walsh AC, Romano PW, Sadda SR.
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4300-7. PubMed ID: 17724220
    [Abstract] [Full Text] [Related]

  • 17. Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration.
    Keane PA, Liakopoulos S, Ongchin SC, Heussen FM, Msutta S, Chang KT, Walsh AC, Sadda SR.
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3115-20. PubMed ID: 18408176
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration using a variable frequency regimen in eyes with no previous treatment.
    Fong KC, Kirkpatrick N, Mohamed Q, Johnston RL.
    Clin Exp Ophthalmol; 2008 Nov; 36(8):748-55. PubMed ID: 19128380
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.